Presentation at 2022 AAD Innovation Academy to Showcase the Risk Stratification of DecisionDx®-Melanoma and its Role in the Management of Patients with Cutaneous Melanoma

FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide…

AAD 2022 to Address Diversity, Health Equity, and Emerging Therapeutics

Emerging research on therapeutics and practical approaches to managing a myriad of dermatological conditions, as well…